Veröffentlichungen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Beule, Dieter Dr. (1) Blüthgen, Nils (1) Bunse, Mario Dr. (3) Chen, Wei Prof. Dr. (1) Edes, Inan Dr. (1) Gavvovidis, Ioannis Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (2) Kammertöns, Thomas Dr. (3) Kettenmann, Helmut Prof. Dr. (2) Ku, Min-Chi Dr. (1) Lorenz, Felix Dr. (4) Lusatis, Simone (1) Niendorf, Thoralf Prof. Dr. (1) Obenaus, Matthias (1) Poncette, Lucia (1) Waiczies, Helmar Dr. (1) Waiczies, Sonia Dr. (1) Wolf, Susanne Dr. (1) Wollert-Wulf, Brigitte (1) (-) Blankenstein, Thomas Prof. Dr. (7) (-) Janz, Martin Dr. (1) (-) Leisegang, Matthias Dr. (7) (-) Mathas, Stephan Dr. (1) (-) Uckert, Wolfgang Prof. Dr. (22) Bioinformatics (1) Biologie maligner Lymphome (19) Experimentelle Ultrahochfeld-MR (1) Genetik und Genomik von Herz- Kreislauferkrankungen (3) Immunregulation und Krebs (1) Mobile DNA (2) Molekulare Immunologie und Gentherapie (20) Molekulare Immuntherapie (3) (-) Molekulare Zellbiologie und Gentherapie (24) Proteom Dynamik (1) Signaltransduktion in Tumorzellen (2) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (1) Zelluläre Neurowissenschaften (2) 1998 (2) 2000 (2) 2003 (5) 2004 (4) 2005 (4) (-) 2006 (3) 2007 (5) 2008 (3) 2009 (3) 2010 (9) (-) 2011 (3) 2012 (4) 2013 (5) 2014 (7) (-) 2015 (7) (-) 2016 (10) 2017 (4) 2018 (3) (-) 2019 (1) 2020 (2) 2021 (4) 24 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Janz, Martin Dr.Leisegang, Matthias Dr.Mathas, Stephan Dr.Uckert, Wolfgang Prof. Dr.Molekulare Zellbiologie und Gentherapie20062011201520162019 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 02. Januar 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein 08. November 2016 in eLife Domain-swapped T cell receptors improve the safety of TCR gene therapy M.T. Bethune M.H. Gee M. Bunse M.S. Lee E.H. Gschweng M.S. Pagadala J. Zhou D. Cheng J.R. Heath D.B. Kohn M.S. Kuhns W. Uckert D. Baltimore 03. November 2016 in Blood In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors M. Richter K. Saydaminova R. Yumul R. Krishnan J. Liu E.E. Nagy M. Singh Z. Izsvák R. Cattaneo W. Uckert D. Palmer P. Ng K.G. Haworth H.P. Kiem A. Ehrhardt T. Papayannopoulou A. Lieber 01. August 2016 in Mol Cancer Ther ERK1 as a therapeutic target for dendritic cell vaccination against high-grade gliomas M.C. Ku I. Edes I. Bendix A. Pohlmann H. Waiczies T. Prozorovski M. Günther C. Martin G. Pagès S.A. Wolf H. Kettenmann W. Uckert T. Niendorf S. Waiczies 01. Juni 2016 in Clin Cancer Res Eradication of large solid tumors by gene therapy with a T cell receptor targeting a single cancer-specific point mutation M. Leisegang B. Engels K. Schreiber P.Y. Yew K. Kiyotani C. Idel A. Arina J. Duraiswamy R.R. Weichselbaum W. Uckert Y. Nakamura H. Schreiber 17. Mai 2016 in Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau 25. April 2016 in Oncoimmunology Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity D. Schirmer T.G.P. Grünewald R. Klar O. Schmidt D. Wohlleber R.A. Rubio W. Uckert U. Thiel F. Bohne D.H. Busch A.M. Krackhardt S. Burdach G.H.S. Richter 06. April 2016 in Sci Rep Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes F. Ebstein K. Textoris-Taube C. Keller R. Golnik N. Vigneron B.J. Van den Eynde B. Schuler-Thurner D. Schadendorf F.K.M. Lorenz W. Uckert S. Urban A. Lehmann N. Albrecht-Koepke K. Janek P. Henklein A. Niewienda P.M. Kloetzel M. Mishto 01. März 2016 in Mol Ther Genome-wide profiling reveals remarkable parallels between insertion site selection properties of the MLV retrovirus and the piggyBac transposon in primary human CD4(+) T cells A. Gogol-Döring I. Ammar S. Gupta M. Bunse C. Miskey W. Chen W. Uckert T.F. Schulz Z. Izsvák Z. Ivics 01. März 2016 in J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
02. Januar 2019 in J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein
08. November 2016 in eLife Domain-swapped T cell receptors improve the safety of TCR gene therapy M.T. Bethune M.H. Gee M. Bunse M.S. Lee E.H. Gschweng M.S. Pagadala J. Zhou D. Cheng J.R. Heath D.B. Kohn M.S. Kuhns W. Uckert D. Baltimore
03. November 2016 in Blood In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors M. Richter K. Saydaminova R. Yumul R. Krishnan J. Liu E.E. Nagy M. Singh Z. Izsvák R. Cattaneo W. Uckert D. Palmer P. Ng K.G. Haworth H.P. Kiem A. Ehrhardt T. Papayannopoulou A. Lieber
01. August 2016 in Mol Cancer Ther ERK1 as a therapeutic target for dendritic cell vaccination against high-grade gliomas M.C. Ku I. Edes I. Bendix A. Pohlmann H. Waiczies T. Prozorovski M. Günther C. Martin G. Pagès S.A. Wolf H. Kettenmann W. Uckert T. Niendorf S. Waiczies
01. Juni 2016 in Clin Cancer Res Eradication of large solid tumors by gene therapy with a T cell receptor targeting a single cancer-specific point mutation M. Leisegang B. Engels K. Schreiber P.Y. Yew K. Kiyotani C. Idel A. Arina J. Duraiswamy R.R. Weichselbaum W. Uckert Y. Nakamura H. Schreiber
17. Mai 2016 in Immunity Thymus-derived regulatory T cells are positively selected on natural self-antigen through cognate interactions of high functional avidity E. Kieback E. Hilgenberg U. Stervbo V. Lampropoulou P. Shen M. Bunse Y. Jaimes P. Boudinot A. Radbruch U. Klemm A.A. Kühl R. Liblau N. Hoevelmeyer S.M. Anderton W. Uckert S. Fillatreau
25. April 2016 in Oncoimmunology Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity D. Schirmer T.G.P. Grünewald R. Klar O. Schmidt D. Wohlleber R.A. Rubio W. Uckert U. Thiel F. Bohne D.H. Busch A.M. Krackhardt S. Burdach G.H.S. Richter
06. April 2016 in Sci Rep Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes F. Ebstein K. Textoris-Taube C. Keller R. Golnik N. Vigneron B.J. Van den Eynde B. Schuler-Thurner D. Schadendorf F.K.M. Lorenz W. Uckert S. Urban A. Lehmann N. Albrecht-Koepke K. Janek P. Henklein A. Niewienda P.M. Kloetzel M. Mishto
01. März 2016 in Mol Ther Genome-wide profiling reveals remarkable parallels between insertion site selection properties of the MLV retrovirus and the piggyBac transposon in primary human CD4(+) T cells A. Gogol-Döring I. Ammar S. Gupta M. Bunse C. Miskey W. Chen W. Uckert T.F. Schulz Z. Izsvák Z. Ivics
01. März 2016 in J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein